Stiripentol for the treatment of pharmacoresistant epilepsy with drug eruptions
Phase 2
Recruiting
- Conditions
- Patients with pharmacoresistant epilepsy with drug eruptions
- Registration Number
- JPRN-UMIN000034986
- Lead Sponsor
- Department of Neurology, Nagoya City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Others than those above
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of Stiripentol for both epileptic seizure and drug eruption
- Secondary Outcome Measures
Name Time Method